The Efficacy of Sequential Gemcitabine and Docetaxel in Intermediate-Risk Non Muscle Invasive Bladder Cancer – Expert Commentary
Non Muscle Invasive Bladder Cancer (NMIBC), Sequential Gemcitabine and Docetaxel, Bacillus Calmette-Guérin (BCG), Gem/Doce. global BCG supply shortage, radical cystectomy, efficacy of sequential Gem/Doce treatment in intermediate-risk NMIBC patients.